Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2001 1
2002 1
2003 2
2004 4
2005 3
2006 2
2007 3
2008 5
2009 1
2010 6
2011 5
2012 6
2014 3
2015 8
2016 10
2017 9
2018 7
2019 9
2020 12
2021 13
2022 8
2023 7
2024 14
2025 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

136 results

Results by year

Filters applied: . Clear all
Page 1
JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis.
Ito T, Masui T, Komoto I, Doi R, Osamura RY, Sakurai A, Ikeda M, Takano K, Igarashi H, Shimatsu A, Nakamura K, Nakamoto Y, Hijioka S, Morita K, Ishikawa Y, Ohike N, Kasajima A, Kushima R, Kojima M, Sasano H, Hirano S, Mizuno N, Aoki T, Aoki T, Ohtsuka T, Okumura T, Kimura Y, Kudo A, Konishi T, Matsumoto I, Kobayashi N, Fujimori N, Honma Y, Morizane C, Uchino S, Horiuchi K, Yamasaki M, Matsubayashi J, Sato Y, Sekiguchi M, Abe S, Okusaka T, Kida M, Kimura W, Tanaka M, Majima Y, Jensen RT, Hirata K, Imamura M, Uemoto S. Ito T, et al. Among authors: ohike n. J Gastroenterol. 2021 Nov;56(11):1033-1044. doi: 10.1007/s00535-021-01827-7. Epub 2021 Sep 29. J Gastroenterol. 2021. PMID: 34586495 Free PMC article.
Effectiveness of Etoposide and Cisplatin vs Irinotecan and Cisplatin Therapy for Patients With Advanced Neuroendocrine Carcinoma of the Digestive System: The TOPIC-NEC Phase 3 Randomized Clinical Trial.
Morizane C, Machida N, Honma Y, Okusaka T, Boku N, Kato K, Nomura S, Hiraoka N, Sekine S, Taniguchi H, Okano N, Yamaguchi K, Sato T, Ikeda M, Mizuno N, Ozaka M, Kataoka T, Ueno M, Kitagawa Y, Terashima M, Furuse J; Japan Clinical Oncology Group (JCOG). Morizane C, et al. JAMA Oncol. 2022 Oct 1;8(10):1447-1455. doi: 10.1001/jamaoncol.2022.3395. JAMA Oncol. 2022. PMID: 35980649 Free PMC article. Clinical Trial.
Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are ≥1.0 cm): clinicopathologic and immunohistochemical analysis of 123 cases.
Adsay V, Jang KT, Roa JC, Dursun N, Ohike N, Bagci P, Basturk O, Bandyopadhyay S, Cheng JD, Sarmiento JM, Escalona OT, Goodman M, Kong SY, Terry P. Adsay V, et al. Among authors: ohike n. Am J Surg Pathol. 2012 Sep;36(9):1279-301. doi: 10.1097/PAS.0b013e318262787c. Am J Surg Pathol. 2012. PMID: 22895264
Japanese classification of pancreatic carcinoma by the Japan Pancreas Society: Eighth edition.
Ishida M, Fujii T, Kishiwada M, Shibuya K, Satoi S, Ueno M, Nakata K, Takano S, Uchida K, Ohike N, Masugi Y, Furukawa T, Hirabayashi K, Fukushima N, Yi SQ, Isayama H, Itoi T, Ohtsuka T, Okusaka T, Inoue D, Kitagawa H, Takaori K, Tani M, Nagakawa Y, Yoshitomi H, Unno M, Takeyama Y. Ishida M, et al. Among authors: ohike n. J Hepatobiliary Pancreat Sci. 2024 Nov;31(11):755-768. doi: 10.1002/jhbp.12056. Epub 2024 Jul 29. J Hepatobiliary Pancreat Sci. 2024. PMID: 39074998 Free PMC article.
Comparison of Ampullary and Pancreatic Adenocarcinomas: Smaller Invasion, Common Adenomatous Components, Resectability, and Histology are Factors for Improved Survival for Patients with Ampullary Adenocarcinoma.
Memis B, Saka B, Pehlivanoglu B, Kim G, Balci S, Tajiri T, Ohike N, Bagci P, Akar KE, Muraki T, Jang KT, Maithel SK, Sarmiento J, Kooby DA, Esmer R, Tarcan ZC, Goodman M, Xue Y, Krasinskas A, Reid M, Basturk O, Adsay V. Memis B, et al. Among authors: ohike n. Ann Surg Oncol. 2025 Mar;32(3):1858-1868. doi: 10.1245/s10434-024-16355-w. Epub 2024 Oct 14. Ann Surg Oncol. 2025. PMID: 39402320
Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to < 10%) Versus 2B (10% to ≤ 20%) Identifies Behaviorally Distinct Subsets in Keeping with the Evolving Management Protocols.
Eren OC, Bagci P, Balci S, Ohike N, Saka B, Sokmensuer C, Leblebici CB, Xue Y, Reid MD, Krasinskas AM, Kooby D, Maithel SK, Sarmiento J, Cheng JD, Taskin OC, Kapran Y, Tarcan ZC, Luchini C, Scarpa A, Basturk O, Adsay NV. Eren OC, et al. Among authors: ohike n. Ann Surg Oncol. 2024 Oct;31(10):7001-7011. doi: 10.1245/s10434-024-15632-y. Epub 2024 Jul 2. Ann Surg Oncol. 2024. PMID: 38955993 Free PMC article.
Stratification of G2 pancreatic neuroendocrine tumors using a Ten Percent Ki-67 index cut-off based on clinicopathological and molecular analyses.
Kageyama Y, Ashida R, Ohike N, Ohshima K, Norose T, Ohgi K, Yamada M, Otsuka S, Kato Y, Kubo H, Uesaka K, Sugiura T, Sugino T, Notsu A, Naruoka A, Nagashima T, Urakami K, Yamaguchi K. Kageyama Y, et al. Among authors: ohike n. Sci Rep. 2025 May 29;15(1):18919. doi: 10.1038/s41598-025-04356-y. Sci Rep. 2025. PMID: 40442332 Free PMC article.
[Ectopic neurotensin-producing tumors].
Ohike N, Nagasaki K. Ohike N, et al. Nihon Rinsho. 2006 Sep 28;Suppl 3:271-3. Nihon Rinsho. 2006. PMID: 17022544 Review. Japanese. No abstract available.
136 results